Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for a range of diseases, and why federal research cuts risk undermining U.S. s ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...

The identification and intervention of Alzheimer's Disease (AD) in its early-stage allows for the timely implementation of lifestyle modifications and therapeutic strategies. Although dysregulation of ...

Federal support for mRNA vaccine research appears in jeopardy after KFF Health News reported Sunday that officials at the National Institutes of Health have directed scientists to remove all ...

Get Instant Summarized Text (Gist) The NIH has reportedly advised scientists to omit mRNA vaccine references from grant applications, suggesting a potential shift away from this research area ...

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their grant applications, two researchers said, in a move that signaled the ...

causing changes in gene expression without changing the DNA sequence itself. Thus, vaccination with mRNA vaccines could lead to an enhanced immune response to future encounters with pathogens ...

causing changes in gene expression without changing the DNA sequence itself. Thus, vaccination with mRNA vaccines could lead to an enhanced immune response to future encounters with pathogens ...

uses a powerful monitoring system to reveal how the human immune system is responsive to a litany of tick triggers — some of which might be leveraged to create a protective mRNA vaccine.

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence.